발간보고서
home > 자료실> 발간보고서
- 글자크기
국내외 원료의약품 산업 현황 및 지원정책 연구
| 작성자 | 관리자 | 카테고리 | 기타 |
|---|---|---|---|
| 작성일 | 2021-12-15 | 조회수 | 1,479 |
| 원문 | https://www.khidi.or.kr/board/view?pageNum=1&rowCnt=10&no1=7&linkId=48866815&menuId=MENU02686&maxIndex=00488669429998&minIndex=00488546179998&schType=0&schText=&schStartDate=&schEndDate=&boardStyle=&c | ||
| 출처 | 한국보건산업진흥원 | ||
| 첨부파일 | |||
국내외 원료의약품 현황 및 지원정책 연구(최종).pdf(3.03MB)제1장 서 론 ·························································································1
1. 연구 배경 ···························································································3
2. 연구 목적 및 방법 ············································································4
제2장 원료의약품의 개요 ···································································7
1. 정의 ···································································································9
2. 원료의약품 산업의 특징 및 중요성 ·············································13
제3장 원료의약품 산업 분석 ····························································17
1. 글로벌 원료의약품 시장의 현황 ···················································19
2. 국내 원료의약품 시장의 현황 ·······················································41
3. 원료의약품 시장의 동향 및 전망 ·················································68
제4장 원료의약품 자급률과 DMF 분석 ···········································83
1. 원료의약품의 자급률 ······································································85
2. 국내 원료의약품 등록 현황 분석 ···············································99
3. 국내 의약품 원료의 중국과 인도 의존도 ··································110
제5장 의약품 공급 중단과 원료 자급화 정책 ·······························119
1. 의약품 자급화 정책 ····································································121
2. 의약품 공급 부족 및 대응 관리 ·················································123
3. 해외 원료 의약품 자급화 정책 ·················································136
4. 의약품 자립화 정책과 GVC 개선 ············································145
5. 원료의약품 산업 육성정책 ··························································153
제6장 원료의약품 자급화 우선 품목 연구 ·····································161
1. 개요 ································································································163
2. 접근법 1) 식약처 지정 품목 기반 접근 ····································166
3. 접근법 2) 중국 및 인도 의존 원료의약품 접근 ······················168
4. 접근법 3) 국가필수의약품 기반의 접근 ··································170
5. 접근법 4) 항생제·항균제 자급화 기반의 접근 ·························172
6. 소결 ································································································174
제7장 글로벌 가치사슬과 COVID-19 ············································175
1. 글로벌 가치사슬과 회복력 ··························································177
2. 주요 국가들의 원료의약품 GVC ················································194
제8장 국산 원료의약품 사용 확대 및 경쟁력 강화 ······················203
1. 국내 원료의약품 자급화 향상을 위한 방안 ······························205
2. 원료의약품 산업 글로벌 경쟁력 제고 방안 ······························224
제9장 국내 원료의약품 산업 설문 조사 ········································235
1. 국내 원료의약품 산업 설문 조사 ···············································237
2. 설문 조사 결과 ···········································································239
3. 결론 및 시사점 ·············································································256
제10장 결론 및 정책 제언 ·····························································261
1. 연구 결과 ·······················································································263
2. 정책 제언 ·····················································································266
▪ 참고문헌 ·····················································································269
▪ 부 록 ·························································································281
【부록 1】 전문가 대상 설문조사표(델파이) ····································283
【부록 2】 기업 대상 설문조사표 ······················································295
